WNY Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Sell |
3,473
-533
| -13% | -$98.9K | 0.07% | 117 |
|
|
2025
Q1 | $839K | Buy |
4,006
+16
| +0.4% | +$3.35K | 0.1% | 101 |
|
|
2024
Q4 | $709K | Sell |
3,990
-517
| -11% | -$91.9K | 0.09% | 107 |
|
|
2024
Q3 | $890K | Sell |
4,507
-540
| -11% | -$107K | 0.1% | 98 |
|
|
2024
Q2 | $866K | Buy |
5,047
+142
| +3% | +$24.4K | 0.11% | 101 |
|
|
2024
Q1 | $893K | Buy |
4,905
+262
| +6% | +$47.7K | 0.14% | 98 |
|
|
2023
Q4 | $719K | Sell |
4,643
-17
| -0.4% | -$2.63K | 0.12% | 111 |
|
|
2023
Q3 | $695K | Buy |
4,660
+98
| +2% | +$14.6K | 0.14% | 99 |
|
|
2023
Q2 | $615K | Sell |
4,562
-194
| -4% | -$26.1K | 0.13% | 101 |
|
|
2023
Q1 | $758K | Sell |
4,756
-741
| -13% | -$118K | 0.18% | 88 |
|
|
2022
Q4 | $888K | Sell |
5,497
-1,007
| -15% | -$163K | 0.24% | 74 |
|
|
2022
Q3 | $871K | Sell |
6,504
-3,514
| -35% | -$471K | 0.32% | 64 |
|
|
2022
Q2 | $1.53M | Buy |
10,018
+2,576
| +35% | +$394K | 0.52% | 48 |
|
|
2022
Q1 | $1.2M | Sell |
7,442
-710
| -9% | -$115K | 0.37% | 61 |
|
|
2021
Q4 | $1.11M | Sell |
8,152
-285
| -3% | -$38.7K | 0.33% | 61 |
|
|
2021
Q3 | $909K | Buy |
8,437
+690
| +9% | +$74.3K | 0.31% | 66 |
|
|
2021
Q2 | $873K | Buy |
7,747
+2,060
| +36% | +$232K | 0.31% | 64 |
|
|
2021
Q1 | $615K | Buy |
5,687
+2,175
| +62% | +$235K | 0.25% | 68 |
|
|
2020
Q4 | $374K | Buy |
+3,512
| New | +$374K | 0.19% | 58 |
|